Clinical and molecular prognostic factors in operable laryngeal cancerVLACHTSIS, Konstantinos; NIKOLAOU, Angelos; MARKOU, Konstantinos et al.European archives of oto-rhino-laryngology. 2005, Vol 262, Num 11, pp 890-898, issn 0937-4477, 9 p.Article

A novel chromatographic method for Ep-CAM mRNA detection in peripheral blood and bone marrow of patients with metastatic colorectal cancerKARANIKIOTIS, Charisios; SKIADAS, Ioannis; KARINA, Maria et al.Anticancer research. 2005, Vol 25, Num 1A, pp 319-323, issn 0250-7005, 5 p.Article

Postoperative dose-dense sequential versus concomitant administration of epirubicin and paclitaxel in patients with node-positive breast cancer : 5-year results of the Hellenic Cooperative Oncology Group HE 10/00 phase III TrialGOGAS, Helen; DAFNI, Urania; CHRISTODOULOU, Christos et al.Breast cancer research and treatment. 2012, Vol 132, Num 2, pp 609-619, issn 0167-6806, 11 p.Article

Weekly Docetaxel with or without Gemcitabine as Second-Line Chemotherapy in Paclitaxel-Pretreated Patients with Metastatic Breast Cancer: A Randomized Phase II Study Conducted by the Hellenic Co-Operative Oncology GroupPAPADIMITRIOU, Christos A; KALOFONOS, Haralambos; ZAGOURI, Flora et al.Oncology. 2009, Vol 77, Num 3-4, pp 212-216, issn 0030-2414, 5 p.Article

G1738R is a BRCA1 founder mutation in Greek breast/ovarian cancer patients : evaluation of its pathogenicity and inferences on its genealogical historyANAGNOSTOPOULOS, Theodore; PERTESI, Maroulio; FOUNTZILAS, George et al.Breast cancer research and treatment. 2008, Vol 110, Num 2, pp 377-385, issn 0167-6806, 9 p.Article

Prognostic significance of autoimmunity during treatment of melanoma with interferonGOGAS, Helen; LOANNOVICH, John; MARKOPOULOS, Christos et al.The New England journal of medicine. 2006, Vol 354, Num 7, pp 709-718, issn 0028-4793, 10 p.Article

Prognostic impact of tumor volumetry in patients with locally advanced head-and-neck carcinoma (non-nasopharyngeal) treated by radiotherapy alone or combined radiochemotherapy in a randomized trialPLATANIOTIS, George A; THEOFANOPOULOU, Maria-Ekaterini; KALOGERA-FOUNTZILA, Anna et al.International journal of radiation oncology, biology, physics. 2004, Vol 59, Num 4, pp 1018-1026, issn 0360-3016, 9 p.Article

Docetaxel and gemcitabine combination, as first-line treatment, in patients with extensive disease small-cell lung cancer. A phase II study of the Hellenic Cooperative Oncology GroupSKARLOS, Dimosthenis-Vasilios; DIMOPOULOS, Athanassios-Meletios; SAMANTAS, Epaminondas et al.Lung cancer. 2003, Vol 41, Num 1, pp 107-111, issn 0169-5002, 5 p.Article

Bax protein expression in colorectal cancer : Association with p53, bcl-2 and patterns of relapseGIATROMANOLAKI, Alexandra; SIVRIDIS, Efthimios; KOUKOURAKIS, Michael I et al.Anticancer research. 2001, Vol 21, Num 1A, pp 253-259, issn 0250-7005Article

Metastatic breast carcinoma confined to bone: Portrait of a clinical entityBRIASOULIS, Evangelos; KARAVASILIS, Vasilis; KOSTADIMA, Lida et al.Cancer. 2004, Vol 101, Num 7, pp 1524-1528, issn 0008-543X, 5 p.Article

Rituximab in combination with vinorelbine/gemcitabine chemotherapy in patients with primary refractory or early relapsed T cell rich B cell lymphoma. A pilot studyXIROS, Nikolaos; ECONOMOPOULOS, Theofanis; VALSAMI, Serena et al.Leukemia research. 2003, Vol 27, Num 12, pp 1097-1099, issn 0145-2126, 3 p.Article

The upgraded role of HER3 and HER4 receptors in breast cancerKOUTRAS, Angelos K; FOUNTZILAS, George; KALOGERAS, Konstantine T et al.Critical reviews in oncology/hematology. 2010, Vol 74, Num 2, pp 73-78, issn 1040-8428, 6 p.Article

Gene expression of estrogen receptor, progesterone receptor and microtubule-associated protein Tau in high-risk early breast cancer: a quest for molecular predictors of treatment benefit in the context of a Hellenic Cooperative Oncology Group trialPENTHEROUDAKIS, George; KALOGERAS, Konstantine T; SAMANTAS, Epaminondas et al.Breast cancer research and treatment. 2009, Vol 116, Num 1, pp 131-143, issn 0167-6806, 13 p.Article

Phase II Study of Sunitinib Administered in a Continuous Once-Daily Dosing Regimen in Patients With Cytokine-Refractory Metastatic Renal Cell CarcinomaESCUDIER, Bernard; ROIGAS, Jan; CHEN, Isan et al.Journal of clinical oncology. 2009, Vol 27, Num 25, pp 4068-4075, issn 0732-183X, 8 p.Article

Trastuzumab Combined with Pegylated Liposomal Doxorubicin in Patients with Metastatic Breast Cancer : Phase II Study of the Hellenic Cooperative Oncology Group (HeCOG) with Biomarker EvaluationCHRISTODOULOU, Christos; KOSTOPOULOS, Loannis; KALOFONOS, Haralabos P et al.Oncology. 2009, Vol 76, Num 4, pp 275-285, issn 0030-2414, 11 p.Article

Palliative chemotherapy in elderly patients with common metastatic malignancies : A Hellenic Cooperative Oncology Group registry analysis of management, outcome and clinical benefit predictorsPENTHEROUDAKIS, George; FOUNTZILAS, George; ECONOMOPOULOS, Theofanis et al.Critical reviews in oncology/hematology. 2008, Vol 66, Num 3, pp 237-247, issn 1040-8428, 11 p.Article

Dose-dense sequential chemotherapy with epirubicin and paclitaxel in advanced breast cancerRAZIS, Evangelia; DIMOPOULOS, Athanassios-Meletios; KOSMIDIS, Paris et al.Cancer investigation. 2001, Vol 19, Num 2, pp 137-144, issn 0735-7907Article

G-CSF induces elevation of circulating CA 15-3 in breast carcinoma patients treated in an adjuvant settingBRIASOULIS, Evangelos; ANDREOPOULOU, Eleni; TOLIS, Chris F et al.Cancer. 2001, Vol 91, Num 5, pp 909-917, issn 0008-543XArticle

19p13.1 Is a Triple-Negative―Specific Breast Cancer Susceptibility LocusSTEVENS, Kristen N; FREDERICKSEN, Zachary; CHANG-CLAUDE, Jenny et al.Cancer research (Chicago, Ill.). 2012, Vol 72, Num 7, pp 1795-1803, issn 0008-5472, 9 p.Article

Expression of Angiogenic Markers in the Peripheral Blood of Patients with Advanced Breast Cancer Treated with Weekly DocetaxelKORANTZIS, Ippokratis; KALOGERAS, Konstantine T; LINARDOU, Helena et al.Anticancer research. 2012, Vol 32, Num 10, pp 4569-4580, issn 0250-7005, 12 p.Article

Phase II Study of Neoadjuvant Imatinib in Glioblastoma: Evaluation of Clinical and Molecular Effects of the TreatmentRAZIS, Evangelia; SELVIARIDIS, Panayotis; KARANASTASI, Sofia et al.Clinical cancer research (Print). 2009, Vol 15, Num 19, pp 6258-6266, issn 1078-0432, 9 p.Article

Greek BRCA1 and BRCA2 mutation spectrum : two BRCA1 mutations account for half the carriers found among high-risk breast/ovarian cancer patientsKONSTANTOPOULOU, Irene; RAMPIAS, Theodore; KARANIKIOTIS, Charisios et al.Breast cancer research and treatment. 2008, Vol 107, Num 3, pp 431-441, issn 0167-6806, 11 p.Article

Evaluation of the Prognostic and Predictive Value of HER-1/EGFR in Breast Cancer Patients Participating in a Randomized Study with Dose-Dense Sequential Adjuvant ChemotherapyTZAIDA, Olympia; GOGAS, Helen; KASTRITIS, Efstathios et al.Oncology. 2007, Vol 72, Num 5-6, pp 388-396, issn 0030-2414, 9 p.Article

Metastatic breast cancer with liver metastases : a registry analysis of clinicopathologic, management and outcome characteristics of 500 womenPENTHEROUDAKIS, George; FOUNTZILAS, George; BAFALOUKOS, Dimitrios et al.Breast cancer research and treatment. 2006, Vol 97, Num 3, pp 237-244, issn 0167-6806, 8 p.Article

The combination of gemcitabine and carboplatin as first-line treatment in patients with advanced urothelial carcinoma : A phase II study of the hellenic cooperative oncology groupBAMIAS, Aristotle; MOULOPOULOS, Lia A; KALOFONOS, Haralambos P et al.Cancer. 2006, Vol 106, Num 2, pp 297-303, issn 0008-543X, 7 p.Article